Latest Paul Stoffels Stories
NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led
NEW BRUNSWICK, N.J., Jan. 21, 2015 /PRNewswire/ -- The Dr. Paul Janssen Award for Biomedical Research today opens its 2015 call for nominations.
-- Further Strengthens Existing Pipeline to Address Infectious Diseases -- NEW BRUNSWICK, N.J., Nov.
-- Deals span new approaches for cancer, diabetes, autoimmune disease and Alzheimer's, exciting technologies such as 3-D printing for trauma use, sedation monitoring, cardiac remodeling, probiotics
NEW BRUNSWICK, N.J., April 29, 2014 /PRNewswire/ -- Johnson & Johnson today announced that its affiliate Janssen Pharmaceutica NV (Janssen) has entered into a novel collaboration with the
PHILADELPHIA, Feb. 25, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc.
NEW BRUNSWICK, N.J., Jan.
Janssen Global Public Health to Oversee R&D and Access Strategy Development for Growing Portfolio of Transformational Medicines BEERSE, Belgium, Jan.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.